Abnormalities of the CEBP alpha transcription factor: a major target in acute myeloid leukemia.
Tenen
D G
DG
Harvard Institutes of Medicine, Boston, MA 02115, USA.
D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000502:physiology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000209:etiology*; D009363:Neoplasm Proteins / Q000502:physiology; D015514:Oncogene Proteins, Fusion / Q000502:physiology
D022763:CCAAT-Enhancer-Binding Protein-alpha; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein